Kanda R, et al. showed that glucagon-like peptide-1 receptor (GLP-1R) promotes autophagy in endometrial cancer, thereby inhibiting its growth and suggesting GLP-1R agonists as a potential therapeutic strategy [31]. Here, GLP1R is linked to endometrial cancer.